Related Experiment Video
Updated: Aug 14, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
Ectopic ACTH-dependent Cushing syndrome in 3 hospitalized patients: lessons learned from management with osilodrostat
Hannah Ruggles1, Emmy Yang2, Nikita Mohan1
1Division of Endocrinology and Metabolism, Department of Internal Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27514, USA.
Insights
Severe Cushing syndrome (CS) is rare and deadly, delaying diagnosis. Rapid osilodrostat treatment effectively manages hypercortisolism and improves outcomes in these critical cases.
Area of Science:
- Endocrinology
- Rare Diseases
- Pharmacology
Background:
- Severe Cushing syndrome (CS) is a rare condition with high mortality.
- Limited clinical experience in managing CS due to its rarity.
- Ectopic ACTH-dependent CS presents unique diagnostic and management challenges.
Abstract:
Severe Cushing syndrome (CS) is a rare diagnosis with high mortality, which limits the ability of endocrinologists to gain experience delivering care. Here we describe our experience treating 3 cases of ectopic ACTH-dependent CS presenting in a single year. The initial diagnosis of each case was made during hospitalization resulting from complications of CS, implicating severe disease and delayed diagnosis. Our experience suggests that rapid initiation and titration of osilodrostat effectively treats hypercortisolism and improves outcomes.
Related Concept Videos
Cushing Syndrome I: Introduction
Cushing Syndrome II: Pathophysiology
Chronic Pancreatitis II: Collaborative Care
Assessment:
Nephrotic Syndrome III : Nursing Management
COPD: Management Using Bronchodilators and Corticosteroids
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids